Trial reportAIDS patient care and STDs2026
Social Capital as Intervention: A Pilot Telehealth Trial (Tele-B6) Among Young Black Sexual Minority Men Living with HIV.
Trial report in AIDS patient care and STDs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05829759 (Brothers Building Brothers by Breaking Barriers for Telehealth Delivery), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Brothers Building Brothers by Breaking Barriers for Telehealth Delivery (Tele-B6)
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Young Black sexual minority men (YB-SMM) who are living with HIV not only face numerous challenges to their health but also demonstrate a range of resilience processes that can be augmented to improve HIV care engagement. We adapted a previously developed in-person group intervention, Brothers Building Brothers By Breaking Barriers, into a remotely delivered telehealth program (Tele-B6), with a goal to enhance existing resilience by building social capital and affirming intersectional identities among YB-SMM living with HIV. We enrolled 60 participants in Atlanta, Georgia, into a pilot randomized controlled trial with a waitlist control design, to examine feasibility, acceptability, and safety of Tele-B6. Our evaluation included brief postsession evaluation surveys, fidelity checklists completed by facilitators, and longitudinal in-depth surveys conducted at baseline and 2-month intervals up through 6 months post-enrollment. Overall, we found that Tele-B6 was feasible to implement, highly acceptable to participants, and safe. Exploratory analyses also suggested potential improvement in general well-being and social capital, though interpretation of these results is limited given the small sample size. Tele-B6 is a promising intervention with potential for scalability and impact for supporting YB-SMM in HIV care.ClinicalTrials.gov registration: NCT05829759.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.